Articles
Page 12 of 20
-
Citation: BMC Pharmacology 2007 7(Suppl 2):A77
-
DIMBOA and DIBOA, two naturally occuring benzoxazinoides, cause aneuploidy in a human-derived liver cell line (HepG2)
Citation: BMC Pharmacology 2007 7(Suppl 2):A75 -
Safety assessment of melanoidins in cell line studies
Citation: BMC Pharmacology 2007 7(Suppl 2):A73 -
Antioxidant and free radical scavenging activities of sumac (Rhus coriaria) and identification of gallic acid as its active principle
Citation: BMC Pharmacology 2007 7(Suppl 2):A71 -
Hospital waste water: health risk for human and environment by cytostatic drug emissions? Part II: Biological monitoring (genotoxicity assays) and risk assessment
Citation: BMC Pharmacology 2007 7(Suppl 2):A70 -
Hospital waste water: health risk for human and environment by cytostatic drug emissions? Part I: Model calculation and chemical monitoring
Citation: BMC Pharmacology 2007 7(Suppl 2):A69 -
Lipid hydroperoxide, an intermediate product of oxidative stress, induces tumour progression-associated genes in hepatocarcinoma cells
Citation: BMC Pharmacology 2007 7(Suppl 2):A67 -
Influence of dissolved organic matter on the bioavailability of hydrophobic organic pollutants in sediments investigated by bioassays
Citation: BMC Pharmacology 2007 7(Suppl 2):A66 -
Impact of stereochemistry on biological effects of permethrin: induction of apoptosis in human hepatoma cells (HCC-1.2) and primary rat hepatocyte cultures
Citation: BMC Pharmacology 2007 7(Suppl 2):A65 -
Cancer and nutrition: role of amino acids (AA) for the regulation of hepatocellular apoptosis
Citation: BMC Pharmacology 2007 7(Suppl 2):A64 -
Control of hepatocellular apoptosis by cytokines (TGF-β1), liver tumor promoter (phenobarbital) and nutritional factors (glucose): approach to validate the hepatoma cell line HCC-1.2 as cell culture model
Citation: BMC Pharmacology 2007 7(Suppl 2):A63 -
β-Sitosterol oxidation products failed to show mutagenic potential in the Ames test
Citation: BMC Pharmacology 2007 7(Suppl 2):A62 -
Influence of an Ironman triathlon on sister chromatid exchanges and high frequency cells
Citation: BMC Pharmacology 2007 7(Suppl 2):A61 -
Investigation of genotoxic effects of inhalative occupational exposure to vanadium: results of a multiple endpoint study
Citation: BMC Pharmacology 2007 7(Suppl 2):A60 -
New epithelial and mesenchymal cell lines from primary liver cancer to study cell interactions in hepatocarcinogenesis
Citation: BMC Pharmacology 2007 7(Suppl 2):A59 -
Role of mesenchymal liver cells in mediating hepatic toxicity and carcinogenesis
Citation: BMC Pharmacology 2007 7(Suppl 2):A58 -
Role of fibroblast growth factors in hepatocarcinogenesis of humans and rats
Citation: BMC Pharmacology 2007 7(Suppl 2):A57 -
Submitochondrial particles from Saccharomyces cerevisiae to screen compounds for antiprotozoal activity
Citation: BMC Pharmacology 2007 7(Suppl 2):A56 -
H2O2 detection with 10-acetyl-3,7-dihydroxyphenoxazine: comparison with homovanillic acid
Citation: BMC Pharmacology 2007 7(Suppl 2):A54 -
Spin trapping experiments with ethyl-substituted EMPO derivatives (EEMPO)
Citation: BMC Pharmacology 2007 7(Suppl 2):A52 -
The peripheral antinociceptive effect of DAMGO and 6β-glycine-substituted 14-O-methyloxymorphone (HS-731) after systemic administration in a mouse visceral pain model
Citation: BMC Pharmacology 2007 7(Suppl 2):A50 -
The possible link between insulin resistance and increased cardiovascular mortality
Citation: BMC Pharmacology 2007 7(Suppl 2):A48 -
Changes in stereotyped behaviour following acute or repeated methylenedioxy-methamphetamine (MDMA) treatment
Citation: BMC Pharmacology 2007 7(Suppl 2):A46 -
Potential role of nociceptin and nocistatin in central regulation of gastric mucosal defense
Citation: BMC Pharmacology 2007 7(Suppl 2):A44 -
Exploring the heterogeneity of use-dependent sodium channel inhibitor drugs. II: Drugs described by the modulated receptor hypothesis (MRH) and/or the guarded receptor hypothesis (GRH)
Citation: BMC Pharmacology 2007 7(Suppl 2):A42 -
Electrophysiological effects of heat shock proteins and dofetilide on cardiac preparations of streptozotocin-induced diabetic rats
Citation: BMC Pharmacology 2007 7(Suppl 2):A40 -
Evidence against a separate high affinity binding site on the P2X3 receptor
Citation: BMC Pharmacology 2007 7(Suppl 2):A38 -
Further evidence for the involvement of 5-HT2C receptors in the pentylenetetrazole model of epilepsy
Citation: BMC Pharmacology 2007 7(Suppl 2):A36 -
New method for detecting ATP release from rat hippocampal slices
Citation: BMC Pharmacology 2007 7(Suppl 2):A34 -
The selective enhancer substance (-)-BPAP counteracts the histological and functional consequences of an experimental stroke in rats
Citation: BMC Pharmacology 2007 7(Suppl 2):A32 -
Influence of the Duffy genotype on pharmacokinetics and pharmacodynamics of recombinant monocyte chemoattractant protein (MCP-1) in vivo
Citation: BMC Pharmacology 2007 7(Suppl 2):A31 -
Effects of high dose prednisolone on optic nerve head blood flow in patients with acute optic neuritis
Citation: BMC Pharmacology 2007 7(Suppl 2):A30 -
Pharmacokinetics of amphotericin B colloidal dispersion in liver failure
Citation: BMC Pharmacology 2007 7(Suppl 2):A28 -
Effects of topical clonidine vs. brimonidine on choroidal blood flow and intraocular pressure during isometric exercise
Citation: BMC Pharmacology 2007 7(Suppl 2):A27 -
Monitoring platelet activation with two different shear-dependent function tests: application of PFA-100 and the Impact-R ARA
Citation: BMC Pharmacology 2007 7(Suppl 2):A26 -
mTORC1 inhibition with rapamycin or LY294002 alone but not in combination leads to AKT phosphorylation via mTORC2 in melanoma cells
Citation: BMC Pharmacology 2007 7(Suppl 2):A25 -
P-Glycoprotein inhibition at the blood-brain barrier visualized with (R)-[11C]verapamil μPET
Citation: BMC Pharmacology 2007 7(Suppl 2):A24 -
Metabolism of (R)-[11C]verapamil in epilepsy patients
Citation: BMC Pharmacology 2007 7(Suppl 2):A23 -
In vivo dose finding of tariquidar using (R)-[11C]verapamil μPET
Citation: BMC Pharmacology 2007 7(Suppl 2):A22 -
Daptomycin elimination by continuous venovenous hemofiltration: in vitro evaluation of factors influencing sieving and membrane adsorption
Citation: BMC Pharmacology 2007 7(Suppl 2):A21 -
Mapping the binding sites for accessory proteins on the A2A adenosine receptor
Citation: BMC Pharmacology 2007 7(Suppl 2):A19 -
Cell adhesion-dependent trafficking and targeting of TRPC4 channels in human vascular endothelium
Citation: BMC Pharmacology 2007 7(Suppl 2):A17 -
Interaction between the selectivity filter and the fast inactivation machinery in the voltage-gated Na+ channel
Citation: BMC Pharmacology 2007 7(Suppl 2):A15 -
State-dependent dissociation of HERG channel inhibitors
Citation: BMC Pharmacology 2007 7(Suppl 2):A13 -
C-terminal splicing reveals intramolecular gating modulation in CaV1.3 L-type Ca2+ channels
Citation: BMC Pharmacology 2007 7(Suppl 2):A11 -
Duramycin effects on voltage-gated ion channels: a QT-prolongation risk?
Citation: BMC Pharmacology 2007 7(Suppl 2):A9 -
PI3Kδ: a double-edged sword in leukemia formation
Citation: BMC Pharmacology 2007 7(Suppl 2):A7 -
SAP102, a novel interaction partner of the A2A adenosine receptor
Citation: BMC Pharmacology 2007 7(Suppl 2):A5 -
GPR55 is a novel cannabinoid receptor
Citation: BMC Pharmacology 2007 7(Suppl 2):A3 -
Neurokinin 1 receptor antagonism promotes active stress coping via enhanced septal 5-HT transmission
Citation: BMC Pharmacology 2007 7(Suppl 2):A1